Research News

---

Topic: Hormonal Therapies (view all topics)

Tags for topic Hormonal Therapies:

• After surgery (also called "adjuvant")
• Arimidex
• Aromasin
• Aromatase Inhibitors
• Before surgery (also called "neoadjuvant")
• Evista
• Fareston
• Faslodex
• Femara
• Not applicable (no surgery)
• Planning Hormonal Therapy
• Prophylactic (to lower risk if you've never been diagnosed with breast cancer)
• Selective Estrogen Receptor Modulators
• Tamoxifen

View articles by month and year

• Hormonal Therapy Before Surgery May Be Good Treatment for Postmenopausal Women with Hormone-Receptor-Positive, Locally Advanced Disease

  Published on October 8, 2011 at 12:00 am

  • Tags: Before surgery (also called "neoadjuvant") and Planning Hormonal Therapy

  Research suggests that hormonal therapy before surgery may be a good alternative to chemotherapy before surgery for postmenopausal women diagnosed with hormone-receptor-positive breast cancer.

• Aromatase Inhibitor Before Surgery May Make Lumpectomy an Option

  Published on September 30, 2010 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, Before surgery (also called "neoadjuvant"), Aromatase Inhibitors, and Planning Hormonal Therapy

  Many women diagnosed with hormone-receptor-positive, early-stage breast cancer for whom mastectomy was recommended may be candidates for lumpectomy after taking an aromatase inhibitor.

• Zometa Before Surgery Doesn’t Seem to Have Benefits

  Published on December 11, 2009 at 12:00 am

  • Tags: Femara and Before surgery (also called "neoadjuvant")

  Research shows that Zometa (chemical name: zoledronic acid) doesn't destroy or slow the growth of breast cancer cells when given before surgery to post-menopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer.